Sample Request Form

Report Title: ALK Tyrosine Kinase Receptor (Anaplastic Lymphoma Kinase or CD246 or ALK or EC 2.7.10.1) - Drugs in Development, 2021

No. Of Pages: 70 Publish Date: Apr-2021
Name:
Email:
Phone:
Company:
Designation:
Country: